ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Yu Liu
Matched on ORCID iD 0000-0002-1282-4897; OpenAlex author ID A5100345711. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 4
- A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12876-023-02748-w↗
- High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12957-021-02147-z↗
- Role of miR-92a-3p/PTEN axis in regulation of pancreatic cancer cell proliferation and metastasis. Co-author DOI 10.11817/j.issn.1672-7347.2020.180459↗
- Development, Validation and Comparison of Artificial Neural Network Models and Logistic Regression Models Predicting Survival of Unresectable Pancreatic Cancer. First author DOI 10.3389/fbioe.2020.00196↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- He Cheng · 2 shared papers, 2021–2023 · strength 0.30
- Yunzhen Qian · 2 shared papers, 2021–2023 · strength 0.30
- Xianjun Yu · 2 shared papers, 2021–2023 · strength 0.30
- Chen Liu · 2 shared papers, 2021–2023 · strength 0.30
- Yusheng Chen · 1 shared paper, 2023 · strength 0.18
- Xu Wang · 1 shared paper, 2023 · strength 0.18
- Xuan Lin · 1 shared paper, 2023 · strength 0.18
- Xuan Zou · 1 shared paper, 2023 · strength 0.18
- Meiliang Li · 1 shared paper, 2020 · strength 0.15
- Yitao Gong · 1 shared paper, 2021 · strength 0.12
- Quanxing Ni · 1 shared paper, 2021 · strength 0.12
- Weiding Wu · 1 shared paper, 2021 · strength 0.12
- Guopei Luo · 1 shared paper, 2021 · strength 0.12
- Kaizhou Jin · 1 shared paper, 2021 · strength 0.12
- Zhou Tong · 1 shared paper, 2020 · strength 0.10
- Peng Zhao · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.